Actively Recruiting
Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial
Led by Navamindradhiraj University · Updated on 2025-05-25
202
Participants Needed
1
Research Sites
114 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.
CONDITIONS
Official Title
Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ESKD patients who have sepsis condition with high interleukin-6 (IL-6 > 50 pg/ml)
You will not qualify if you...
- Patients who need dialysis with continuous kidney replacement therapy
- Vulnerable patients including pregnant women
- Patients expected to pass away within 24 hours
- Patients with a history of allergic reaction to the dialyzers used in this trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Navamindhradhiraj university
Dusit, Bangkok, Thailand, 11130
Actively Recruiting
Research Team
P
Punnawit Laungchuaychok, MD
CONTACT
W
Wanjak Pongsittisak, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here